Kristian Stengaard-Pedersen (K Stengaard-Pedersen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Disease Activity

Extracellular Matrix

Rheumatoid Arthritis Patients

Top Venues

Scandinavian journal of rheumatology

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Signe Møller-Bisgaard, Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, Bo Ejbjerg, Merete Lund Hetland, Jakob Møllenbach Møller, Sabrina Mai Nielsen, Daniel Glinatsi, Cecilie Lerche Nordberg, Kristian Stengaard-Pedersen, Ole Rintek Madsen, Bente Jensen, Jan Alexander Villadsen, Ellen Margrethe Hauge, Oliver Hendricks, Hanne M Lindegaard, Niels Steen Krogh, Anne Grethe Jurik, Henrik S Thomsen, Robin Christensen, Mikkel Østergaard
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial. RMD open 10 (1) (2024)
Signe Møller-Bisgaard, Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, Bo Ejbjerg, Merete Lund Hetland, Jakob Møllenbach Møller, Sabrina Mai Nielsen, Daniel Glinatsi, Cecilie Lerche Nordberg, Kristian Stengaard-Pedersen, Ole Rintek Madsen, Bente Jensen, Jan Alexander Villadsen, Ellen Margrethe Hauge, Oliver Hendricks, Hanne M Lindegaard, Niels Steen Krogh, Anne Grethe Jurik, Henrik S Thomsen, Robin Christensen, Mikkel Østergaard
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial. RMD open 10 (1) (2024)
Signe Møller-Bisgaard, Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, Bo Ejbjerg, Merete Lund Hetland, Jakob Møllenbach Møller, Sabrina Mai Nielsen, Daniel Glinatsi, Cecilie Lerche Nordberg, Kristian Stengaard-Pedersen, Ole Rintek Madsen, Bente Jensen, Jan Alexander Villadsen, Ellen Margrethe Hauge, Oliver Hendricks, Hanne M Lindegaard, Niels Steen Krogh, Anne Grethe Jurik, Henrik S Thomsen, Robin Christensen, Mikkel Østergaard
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial. RMD open 10 (1) (2024)
Signe Møller-Bisgaard, Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, Bo Ejbjerg, Merete Lund Hetland, Jakob Møllenbach Møller, Sabrina Mai Nielsen, Daniel Glinatsi, Cecilie Lerche Nordberg, Kristian Stengaard-Pedersen, Ole Rintek Madsen, Bente Jensen, Jan Alexander Villadsen, Ellen Margrethe Hauge, Oliver Hendricks, Hanne M Lindegaard, Niels Steen Krogh, Anne Grethe Jurik, Henrik S Thomsen, Robin Christensen, Mikkel Østergaard
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial. RMD open 10 (1) (2024)
Morten Aagaard Nielsen, Ditte Køster, Akul Y Mehta, Kristian Stengaard-Pedersen, Pierre Busson, Peter Junker, Kim Hørslev-Petersen, Merete Lund Hetland, Mikkel Østergaard, Malene Hvid, Hakon Leffler, Tue W Kragstrup, Richard D Cummings, Bent Winding Deleuran
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts. Cells 12 (2) (2023)
Morten Aagaard Nielsen, Ditte Køster, Akul Y Mehta, Kristian Stengaard-Pedersen, Pierre Busson, Peter Junker, Kim Hørslev-Petersen, Merete Lund Hetland, Mikkel Østergaard, Malene Hvid, Hakon Leffler, Tue W Kragstrup, Richard D Cummings, Bent Winding Deleuran
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts. Cells 12 (2) (2023)
Morten Aagaard Nielsen, Ditte Køster, Akul Y Mehta, Kristian Stengaard-Pedersen, Pierre Busson, Peter Junker, Kim Hørslev-Petersen, Merete Lund Hetland, Mikkel Østergaard, Malene Hvid, Hakon Leffler, Tue W Kragstrup, Richard D Cummings, Bent Winding Deleuran
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts. Cells 12 (2) (2023)
Morten Aagaard Nielsen, Ditte Køster, Akul Y Mehta, Kristian Stengaard-Pedersen, Pierre Busson, Peter Junker, Kim Hørslev-Petersen, Merete Lund Hetland, Mikkel Østergaard, Malene Hvid, Hakon Leffler, Tue W Kragstrup, Richard D Cummings, Bent Winding Deleuran
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts. Cells 12 (2) (2023)
Morten Aagaard Nielsen, Ditte Køster, Akul Y Mehta, Kristian Stengaard-Pedersen, Pierre Busson, Peter Junker, Kim Hørslev-Petersen, Merete Lund Hetland, Mikkel Østergaard, Malene Hvid, Hakon Leffler, Tue W Kragstrup, Richard D Cummings, Bent Winding Deleuran
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts. Cells 12 (2) (2023)
Mogens Pfeiffer Jensen, Donghua Liao, U Tarp, Bent Winding Deleuran, Kristian Stengaard-Pedersen, Jacob Venborg, Birgitte Brock, Christina Brock
Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial. Scandinavian journal of rheumatology (2022)
Dženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, Kim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, Mikkel Østergaard, Christian Ammitzbøll, Sören Möller, Robin Christensen, Torkell J Ellingsen
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial. Rheumatology international 41 (3) (2021)